Skip to main content
Clinical Trials/ACTRN12609000315213
ACTRN12609000315213
Completed
N/A

Does vibration therapy improve physical function and strength in children and adolescents with mitochondrial disorders or Rett syndrome?

Children's Hospital at Westmead0 sites50 target enrollmentMay 21, 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mitochondrial respiratory chain disorders
Sponsor
Children's Hospital at Westmead
Enrollment
50
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 21, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • For the mitochondrial patients \- Children and adolescents aged between 8 – 18 years with a proven mitochondrial respiratory chain disorder, based on positive enzymology in muscle biopsies
  • for the Rett syndrome patients \- Children with Rett syndrome, with known pathogenic Methyl CgP binding protein 2 (MECP2\) mutations, up to the age of 18 years

Exclusion Criteria

  • for mitochondrial patients \- anything more than mild cognitive impairment which would impede the ability of test subjects to comply with testing; severe myopathy preventing subjects from being able to stand on the vibration platform for at least 10 minutes; 25\-hydroxyvitamin D level \< 50 nmol/L; lower limb fracture within the preceding 6 months; use of a medication known to increase bone mass, eg bisphosphonates
  • for Rett syndrome patients \- inability to stand unaided or with the support of a frame on the vibration platform for at least 10 minutes; 25\-hydroxyvitamin D level \< 50 nmol/L; limb fracture within the preceding 6 months; use of a medication known to increase bone mass, eg bisphosphonates

Outcomes

Primary Outcomes

Not specified

Similar Trials